U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
Azerbaijani troops continue with their infiltration attempts in various sections of the borer with Armenia and line of contact.
The body of an Azerbaijani soldier was left in the territory between Armenian and Azerbaijani military positions.
United States planned to start issuing visas in accordance with a new reciprocal arrangement beginning January 1, 2015.
“This exercise aims to empower youth by giving them an opportunity to network,” head of the OSCE Office in Yerevan said.
Partner news